Ming-Jin Jheng

Most-cited papers

1. An anti-CTLA-4 heavy chain–only antibody with enhanced Treg depletion shows excellent preclinical efficacy and safety profile

   X. Gan, Qianqian Shan, Hetal Li, R. Janssens +14 more

   2022Proceedings of the National Academy of Sciences of the United States of America46 citations Open access

   Semantic Scholar

   Save

2. Ser262 determines the chloride-dependent colour tuning of a new halorhodopsin from Haloquadratum walsbyi

   H. Fu, Yung-Ning Chang, Ming-Jin Jheng, Chii-Shen Yang

   2012Bioscience Reports5 citations Open access

   Semantic Scholar

   Save

3. Abstract 576: Discovery of FL801, a B7-H3-targeting nanobody-based radioligand vector, using Clear-XTM linker technology

   Xiaozhu Wang, Ming-Jin Jheng, Peng-Yun Li, Dian Li +4 more

   2025Cancer Research0 citations

   Semantic Scholar

   Save

4. Correction for Gan et al., An anti-CTLA-4 heavy chain–only antibody with enhanced Treg depletion shows excellent preclinical efficacy and safety profile

   X. Gan, Qianqian Shan, R. Janssens, Yü-Chen Shen +13 more

   2023Proceedings of the National Academy of Sciences of the United States of America0 citations Open access

   Semantic Scholar

   Save

5. Correction for Gan et al., An anti-CTLA-4 heavy chain–only antibody with enhanced Treg depletion shows excellent preclinical efficacy and safety profile

   X. Gan, Qianqian Shan, Hetal Li, R. Janssens +14 more

   2022Proceedings of the National Academy of Sciences of the United States of America0 citations Open access

   Semantic Scholar

   Save